Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccination in Healthcare Personnel to Reduce Severity of COVID-19
NCT04362124Phase 3Withdrawn
- Sponsor
- Universidad de Antioquia
- Start
- Aug 2020
- Primary completion
- Jun 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bcg vaccine in coronavirus disease 2019 (COVID-19), sponsored by Universidad de Antioquia. Planned start Aug 2020; status: withdrawn.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04362124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04362124.